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Background: Microbial transglutaminase (mTG) is a robust enzyme catalyzing the formation of an isopeptide
bond between glutamine and lysine residues. It has found use in food applications, pharmaceuticals, textiles, and
biomedicine. Overexpression of soluble and active mTG in E. coli has been limited due to improper protein folding
and requirement for proteolytic cleavage of the pro-domain. Furthermore, to integrate mTG more fully industrially
and academically, thermostable and solvent-stable variants may be imperative.
Results: A novel expression system constitutively producing active mTG was designed. Wild-type (WT) mTG and a
S2P variant had similar expression levels, comparable to previous studies. Kinetic constants were determined by a
glutamate dehydrogenase-coupled assay, and the S2P variant showed an increased affinity and a doubled enzyme
efficiency towards Z-Gln-Gly. The melting temperature (Tm) of the WT was determined by intrinsic fluorescence
measurements to be 55.8 ± 0.1 °C and of the S2P variant to be 56.3 ± 0.4 °C and 45.5 ± 0.1 °C, showing a moderately
different thermostability profile. Stability in water miscible organic solvents was determined for both the WT and
S2P variant. Of the solvents tested, incubation of mTG in isopropanol for 24 h at 4 °C showed the strongest
stabilizing effect with mTG retaining 61 and 72% activity for WT and S2P respectively in 70% isopropanol. Both
enzymes also showed an increased initial activity in the presence of organic solvents with the highest activity
increase in 40% DMSO. Nevertheless, both enzymes were inactivated in 70% of all organic solvents tested.
Conclusions: A constitutive expression system of active mTG in E. coli without downstream proteolytic cleavage
processing was used for overexpression and characterization. High throughput techniques for testing
thermostability and kinetics were useful in streamlining analysis and could be used in the future for quickly
identifying beneficial mutants. Hitherto untested thermostability and stability of mTG in organic solvents was
evaluated, which can pave the way for use of the enzyme in novel applications and processes.
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Transglutaminase (EC 2.3.2.13, protein-glutamine gamma-
glutamyltransferase, TG) catalyzes the acyl transfer reac-
tion between γ-carboxyamide groups (acyl donor) and
primary amines (acyl acceptor). In proteins, it is able to
crosslink the γ-carboxyamide of glutamine and the* Correspondence: afishman@tx.technion.ac.il
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ceptors can be used, such as esterified threonine, serine,
cysteine, and tryptophan [1]. In humans, TG is involved in
formation of clots, wound repair, epidermal keratinization,
and membrane curing [2], but in plants it functions in
structural modification of specific protein substrates and
programmed cell death [3].
In Nature, TG are prevalent in all life domains includ-
ing plants [3], mammals [4], and microorganisms [2].
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size, and composed of a single domain instead of multi-
domains. The active domain in all sources contains a
catalytic triad composed of Cys, His and Asp, although
the configuration differences suggest a convergent evolu-
tion model [5–7]. mTG are robust enzymes retaining
activity over a wide range of pH and temperature [8].
mTG from Streptomyces mobaraensis, the only commer-
cially available enzyme [2], is expressed extracellularly as
a zymogen containing an N-terminal pro-domain re-
quired for proper folding that covers the active site along
with an extracellular protease that cleaves off the pro-
domain thus producing the mature active enzyme [5].
mTG has been accepted as Generally Recognized as
Safe (GRAS) by the FDA since 1998, and has subse-
quently been widely used in the food and textile indus-
tries for modifying proteins [9, 10]. It is commonly used
in the restructuring of meat products, thickening of
yoghurts, coagulation alternatives for tofu, and more re-
cently in molecular gastronomy [9, 11]. In textiles it has
been used successfully to improve shrink resistance, ten-
sile strength, and color retention, and to crosslink pro-
teins into leather to fill voids [10]. Increasingly it is also
being studied in the biomedical industry for site-specific
PEGylation of proteins, antibody modifications, and
crosslinking hydrogels for drug delivery [1].
Commercial production of mTG has focused mainly
on wild-type Streptomyces spp. yielding extracellular en-
zyme with activity up to 6.0 U/ml which is considered
low industrially [12]. Furthermore, it is not a convenient
system for producing improved variants with tailored
properties. Other expression systems using genetically
modified microorganisms have been studied, including
Corynebacterium spp., Escherichia coli, and Candida
boidinii, although these were unable to out-produce the
native Streptomyces spp. [12]. Therefore, generation of
high yield recombinant mTG in E. coli would be useful
in biotechnology being a widely studied system with
availability of high level expression vectors and strains
[13]. E. coli is already used for production of nearly 30%
of therapeutic recombinant proteins [13], and is a com-
monly used platform for enzyme engineering. Moreover,
recombinant overexpression of foreign proteins in E. coli
can constitute over 45% of total protein produced,
highlighting the potential [14].
Initial studies on cloning and expression of soluble
Streptomyces spp. mTG in E. coli had limited success
due to the formation of inclusion bodies or low yields
[12]. Recent studies have been able to produce high
levels of chemically renatured mTG fusion proteins from
inclusion bodies [15]. Other production systems involve
a secondary in-vitro protease activation step to remove
the pro-domain [16], or by introduction of a protease
recognition site, and co-expression of the protease withthe mTG [17]. An elegant approach reported by Liu
et al. [18] has been the cloning of a polycistronic gene
with the pro-domain required for proper folding and the
mature enzyme after cleavage expressed by the same T7
promoter noncovalently one following the other. The
expressed products were secreted into the periplasm for
proper folding and protease protection. This method
avoids downstream proteolytic cleavage, simplifying the
production of active mTG.
In recent years there has been a strong push for indus-
trial processes to become “greener”, which includes in-
creased efficiency, increased safety of the process and of
the final product, and benign to the environment [19].
Integration of enzymatic biocatalysts into industrial pro-
cesses has proven itself as one way to achieve these
goals. Enzymes are able to work in mild conditions while
still achieving high activity, and have inherent selectivity,
thus increasing efficiency and decreasing waste [20, 21].
On the other hand, there is an incentive to increase the
thermostability and solvent stability of functional en-
zymes. Higher temperatures enhance chemical reaction
rates, increase solubility, and decrease contaminant risk
by microorganisms, although most enzymes evolved in
mesophilic conditions, such as mTG, are prone to
denaturation at temperatures used industrially [22]. Or-
ganic solvents are commonly used in industrial applica-
tions and solvent-stability of enzymes holds several
advantages, such as increased solubility of hydrophobic
substrates, protection from undesired hydrolytic reac-
tions, and shifting of the thermodynamic equilibriums
towards synthesis [23].
The present work describes an improved strategy for
cloning and constitutive expression of soluble active
mTG from Streptomyces mobaraensis in E. coli, and the
subsequent purification and characterization of the en-
zyme. Thermal and organic solvent stability of the wild-
type (WT) and variant S2P were studied for the first
time while the kinetic constants were measured using a
modified version of a recently reported assay allowing a
rapid comparison between the enzymes. Additionally,
the S2P enzyme was tested for crosslinking soy protein
isolate to compare it to the WT mTG in an actual food
application.
Results and discussion
Cloning, expression, and purification of a recombinant
mTG in E. coli
The main goal of the present work was to use E. coli as
an efficient expression system for the production of an
active and soluble mTG from Streptomyces mobaraensis.
Of the methods described in the literature and
highlighted in the Background, that of Liu et al. [18]
comprising a polycistronic gene with the pro-domain
and the active gene was the most promising starting
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secreted into the periplasm. Expression of recombinant
proteins in the periplasm facilitates the successful fold-
ing of enzymes, reducing the formation of inclusion bod-
ies [24]. Additionally, periplasm production may help
reduce enzyme degradation by cytosolic proteases [25].
The synthetic operon construct (based on GenBank:
KX775947) consisted of two parts: i) a gene encoding
the pro-domain crucial for proper folding of the enzyme
and ii) the gene encoding the mTG thermostable variant
S2P [26], with a C-terminal His-tag. Each part was
paired with a preceding PelB secretory sequence (Fig. 1).
Primers which included the NdeI and BamHI restriction
sites were used to amplify the synthetic construct, and
clone it into a pET9a vector for transformation into E.
coli BL21 (DE3) cells. The sequence was confirmed by
sequence analysis after transformation. The change from
the pET22b used by the original group, to a constitutive
vector pET9a helped streamline the expression, negating
the addition of an inducer following an incubation
period, while still achieving comparable levels of
expression.
In order to compare the mutant to the WT enzyme,
primers were designed with the P2S site reversion muta-
tion. The plasmid was extracted and amplified using the
primers, after which DpnI enzyme was used to digest
the template plasmid. Separately, the S2P construct was
transferred into a pET22b vector for expression in E. coli
BL21 (DE3) cells, to compare the constitutive expression
of the pET9a with the inducible expression of pET22b
used by the original group [18].
The cells were grown in separate batches, disrupted,
and the mTGs were purified by affinity chromatography
on a nickel column. The resulting purified enzymes were
compared on an SDS-PAGE gel, and by spectroscopy for
purity and concentration. All expression vectors led to
comparable enzyme purity and concentrations of 120 mg/
L or 1 U/ml.
This expression system allows production of active
mTG without requiring any further processing steps
such as renaturing from inclusion bodies or cleavage of
a pro-enzyme to yield the active enzyme [15–17, 27].
Such methods require time, while these changes allow
for a faster expression which more closely resembles the
current industrial production which purifies active mTG
from Streptomyces without any activation step. An ad-
vantage with this expression system in the containmentFig. 1 Synthetic mTG construct used for transformation of E. coli BL21 (DE3
domain required for folding and the mTG gene separately expressed. Each
whereupon folding will occur in the periplasm. Another ribosome bindingof the active enzyme intracellularly, reducing the work-
ing volume for extraction as opposed to an extracellular
extraction. In addition, the constitutive expression sys-
tem shows that accumulation of active mTG in the peri-
plasm is not completely toxic to E. coli as previously
thought [15, 28].
A further increase in expression levels may be possible
by co-expressing periplasmic secretory proteins, since
secretion into the periplasm is frequently the limiting
factor for production [24]. Another strategy could in-
clude using periplasm protease deficient E. coli strains
which would reduce enzyme degradation [24].
In order to compare the purified enzyme produced
using the constitutive expression system to previous re-
ports, WT and S2P variant were biochemically charac-
terized. Furthermore, thermostability and organic
solvent stability were assessed.
Kinetic properties of WT and S2P mutant
The S2P variant was produced by random mutagenesis
of the WT enzyme, and found to be more thermostable
- able to withstand incubation at 60 °C - and more active
than the WT [26, 29]. The kinetic constants of WT
mTG and variant S2P were determined using the
coupled enzyme reaction proposed by Oteng-Pabi and
Keillor [30]. The enzymatic transamidation reaction be-
tween a γ-glutamyl donor (Z-Gln-Gly) and hydroxyl-
amine releasing ammonia was coupled to the glutamate
dehydrogenase (GDH)-catalyzed reductive amination of
α-ketoglutarate (α-KG). The activity of GDH is
dependent on NADH as a co-factor, whose disappear-
ance can be monitored at 340 nm. NADH concentration
was calculated based on a calibration curve, which in
turn was used to calculate activity of mTG. The enzymes
analyzed were the WT and the S2P variant purified from
E. coli harboring the pET9a vector. The activity profile
followed Michaelis-Menten kinetics, and the results are
presented in Table 1.
As evident from Table 1, the Km value was 3-fold
lower for the mutant as compared to the WT, indicating
a higher affinity for the substrate. Conversely, the turn-
over number was higher for the WT enzyme, although
the enzymatic efficiency was 2-fold higher for the
mutant.
The kinetic constants for the S2P variant had not been
determined beforehand, although it had been found to
be more stable and active [26, 29]. The assay used in this) cells. The construct consists of restriction enzyme sites, the pro-
one has a preceding PelB sequence to direct periplasm secretion,
site (RBS) precedes the mTG gene to ensure proper translation
Table 1 Kinetic constants of WT and S2P variant measured by
the mTG-GDH coupled enzyme methoda
Variant Km (mM) kcat (1/s) kcat/Km (1/s⋅mM)
WT 11.6 ± 0.3 0.850 ± 0.007 0.073 ± 0.002
S2P 4.2 ± 0.1 0.60 ± 0.01 0.141 ± 0.002
aResults are the average of three independent experiments with 5 assay
repetitions in each experiment
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comparison between different variants. The results show
(Table 1) that variant S2P has a statistically significant
lower Km value than WT (4.2 mM and 11.6 mM respect-
ively, p = 0.002). These values deviate from the literature
values for WT mTG (40–55 mM) [5, 30, 31], although
different assay conditions or different substrates can ac-
count for these discrepancies. Oteng-Pabi and Keillor
who developed the continuous assay [30], used Gly-
OMe instead of hydroxylamine as the acyl acceptor,
which could result in different kinetic constants than ob-
tained here. In addition, their mTG was activated by in-
cubation with trypsin, which leaves a FRAP peptide
from the pro-domain on the C terminal of the mature
mTG [32], and is therefore a slightly different enzyme.
Other groups [5, 31] who determined kinetic constants
used the standard hydroxamate procedure [30, 33],
which is an endpoint assay rather than a continuous
method, which determines the rate of reaction based on
a single point instead of multiple points. Additionally,
Zhang and co-workers used a native mTG without a
His-tag, which again, may alter the kinetic properties to
some extent [31]. Finally, the coupled reaction is per-
formed at pH 7.2, while the other groups used pH of 6.0
as per the standard hydroxamate assay.
Nonetheless, these results, coupled with the vari-
ants’ increased enzyme efficiency (kcat/Km) of 0.14 1/Fig. 2 Melting scan of the fluorescence ratio versus temperature (a) and fir
represent an average of duplicatess⋅mM versus 0.07 1/s⋅mM for the WT, support the
increased activity found previously [29]. However, the
S2P’s decreased turnover number (kcat) supports the
notion of a reduced activity at higher concentrations.
The difference between these results and the previous
findings for the S2P having a higher specific activity
than the WT enzyme may be explained by the hydro-
xamate activity assay protocol being done at a sub-
strate concentration below the Vmax [30, 33]. Using a
lower substrate concentration, the variant, having a
lower Km, would show increased activity compared to
the WT, although at higher substrate concentrations
those differences disappear. Therefore, although the
S2P variant does show an increased affinity and
efficiency, its benefit is only seen at lower substrate
concentrations, and further highly active mutant
characterization should also focus on activity assays at
higher substrate concentrations to ensure enzyme
saturation.
Thermostability of WT and S2P mTG
For industrial applications, a highly thermostable mTG
could be beneficial. Variant S2P was found to have a sig-
nificantly increased residual activity after incubation at
60 °C compared to the WT enzyme [26]. Thermal stability
of the enzyme itself as opposed to residual activity after
incubation was tested here for the first time using a differ-
ential scanning fluorimeter (nanoDSF) (Fig. 2). This in-
strument measures the change in fluorescence of tyrosine
and tryptophan amino acids upon protein unfolding at in-
creasing temperatures [34]. In the fluorescence ratio, and
in the first derivative, there are two inflection points and
melting temperatures (Tm) for the S2P variant while the
WT has only one Tm. Height of peaks is related to protein
concentration and not to thermostability. The peak of thest derivate versus temperature (b) of WT and S2P variant. Results
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enzyme, and showed an additional peak at a lower
temperature. Results of the DSF measurement are sum-
marized in Table 2 based on the built-in software.
As can be seen from Fig. 2 and Table 2, the mutant
unfolded at a slightly higher temperature (56.3 °C vs.
55.8 °C) indicating improved thermostability although
not statistically significant. Additionally, a second Tm
was observed at 45.5 °C for the variant but not for the
WT enzyme. Position two is important for stabilization
of two loops in mTG [35], and the substitution of the
polar serine to the apolar proline may diminish these loop
interaction and cause a secondary melting temperature in
this region. The nanoDSF may therefore offer a fast high-
throughput test for thermostability and help explain
conformational changes of mutations previously accessible
by crystal structure determination only. Furthermore, the
determination of the WT Tm allows for future comparison
to other thermostable variants.
Stability in organic solvents
Enzymatic stability in organic solvents is an important
property in applied biocatalysis and for some industrial
applications [36]. In the pharmaceutical industry for ex-
ample, there is a high use of organic solvents for the entire
process of drug production including solubilizing, extract-
ing, crystallization, and reacting with the drug [35]. More-
over, in the textile industry, organic solvents are important
for dyeing leather [36], and for finishing, scouring, desiz-
ing, and coating of fabrics [37]. Use of mTG has been
studied for some processes in the pharmaceutical industry
[38, 39] and textile industry [10, 40, 41], although increas-
ing the stability in organic solvents may allow more wide-
spread acceptance and integration.
In order to characterize mTG stability in organic sol-
vents two tests were performed. The first was incubation
overnight at 4 °C in the presence of organic solvents
followed by measurement of the residual activity (Fig. 3).
This temperature was chosen to minimize mTG self-
polymerization. The second was performing the activity
assay in the presence of organic solvents and comparing
them to the activity in buffer (Fig. 4). The organic sol-
vents used included water-miscible methanol (MeOH),
ethanol (EtOH), isopropanol, and dimethyl sulfoxide
(DMSO).
Enzyme stability differed among the organic solvents
tested. The residual activity was stable after incubationTable 2 Results of denaturation temperatures of WT and S2P
mTG enzymes as determined by nanoDSFa
Variant Tm 1 (°C) Tm 2 (°C)
WT 55.8 ± 0.1 -
S2P 56.3 ± 0.4 45.5 ± 0.1
a Results are the average of duplicatesin low-range concentrations of methanol and isopropa-
nol (0–30%), while there was a decrease in activity in
ethanol and DMSO starting from 10%. mTG seems par-
ticularly stable in isopropanol, retaining ~61 and ~72%
activity for WT and S2P respectively in 70% isopropanol
(Fig. 3). The mutant enzyme showed comparable stabil-
ity as the WT in most organic solvents, although had a
higher residual activity in isopropanol.
As opposed to 24-h incubation, activity in the pres-
ence of organic solvents had a different stability profile
(Fig. 4). The activity of WT and S2P was highest in
DMSO followed by MeOH, EtOH, and isopropanol. The
S2P mutation also seemed to have a negligible influence
on the activity in most organic solvents, although activ-
ity in isopropanol was reduced. The activity in the pres-
ence of 10–30% organic solvents also increased, with the
highest activity seen in 40% DMSO. Similar results have
been previously shown for tyrosinase from Bacillus
megaterium [42]. At 70% concentration, activity in all
tested organic solvents ceased, indicating a maximum
usable concentration, at least for the solvents evaluated.
All solvents tested were polar, more capable of pene-
trating into the enzyme core and inducing conform-
ational changes than non-polar solvents [43]. The
increased activity following incubation in organic sol-
vents may be linked to induction of different stable con-
formations, while the increased activity in organic
solvents may be linked to a looser conformation which
could ease entrance of substrates into the catalytic
pocket. Loss of activity at higher concentrations is likely
caused by denaturation of the enzyme [44], although the
increased residual activity in high concentrations of iso-
propanol is unexpected which warrants further study
and may make it an excellent storage medium for mTG.
Another possibility is that the organic solvents improve
the selectivity of the enzyme, as has been shown with
other enzymes [42, 45]. As noted previously all of the
tested organic solvents are commonly used in the
pharmaceutical industry [35], and by knowing the stabil-
ity of mTG in various solvents, it might be possible to
combine current drug production with novel applica-
tions of mTG such as antibody drug conjugates [39].
Crosslinking of soy protein isolate (SPI)
mTG is mostly used in food applications for modulating
texture and rheological properties [27, 46–48]. The WT
mTG had been shown previously to crosslink soy pro-
tein isolate (SPI) [49]. The S2P variant was therefore
tested here for its ability to crosslink SPI, ensuring the
mutation did not hinder the ability to crosslink native
proteins, and reconfirming the validity of the activity
assay. S2P was incubated with a 1% solution of SPI at a
1:50 gr/gr concentration of mTG to SPI for 4 h, and run
on an SDS-PAGE (Fig. 5).
a b
Fig. 3 Effect of organic solvents on residual activity of mTG after incubation for 24 h at 4 °C. WT (a) and S2P (b) were assayed for activity after
incubation using the standard hydroxamate assay. Activity of mTG incubated in 50 mM sodium phosphate buffer pH 8 was designated as 100%
activity, and used for comparison. Results represent an average of duplicates
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molecular weight products at the top of the stacking gel,
and the top of the separating gel, in addition to the
disappearance of the β-conglycinin and acidic subunit
glycinin protein bands. In addition, the control of mTG
alone and SPI alone confirm that the crosslinking was
done by the mTG and not spontaneously, and that the
mTG is stable over 4 h. The activity of S2P was consist-
ent with that of WT mTG in its ability to crosslink β-
conglycinin and acidic subunits of glycinin but not theFig. 4 Effect of organic solvents on the activity of mTG; WT (a) and S2P (b)
addition of varying concentrations of organic solvents. 100% activity was d
represent an average of triplicatesbasic subunits of glycinin [50]. These findings, in
addition to the kinetic results highlight that although
S2P mTG has a lower Km it is still limited to specific
substrates.
Conclusions
This is the first time that active and soluble mTG has
been overexpressed in a constitutive vector in E. coli
without requiring any downstream processing as proteo-
lytic digestion of renaturation from inclusion bodies.. The standard hydroxamate activity assay was performed with the
efined as the activity in 50 mM sodium phosphate buffer pH 8. Results
Fig. 5 SPI crosslinking by S2P mTG for 4 h. From left to right: lanes 1–2 present SPI alone at 0 min and at 4 h; lanes 3–9 show SPI with mTG at
0 min, 15 min, 30 min, 45 min, 1 h, 2 h, 4 h, respectively; lanes 10–11 present mTG alone at 0 min and at 4 h; M is the protein size ladder. The
SDS-PAGE was run using 15 μl per well from each fraction
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continuous kinetic analysis was able to quantify the
improvement of a known variant. The thermostability
characteristics were also determined in a novel fashion
using intrinsic fluorescence measurement, perhaps enab-
ling a faster alternative to current assays. Finally, the en-
zymes were evaluated for activity in organic solvents,




Z-Gln-Gly as a γ-glutamyl donor substrate was pur-
chased from Sigma-Aldrich (Rehovot, Israel), and hy-
droxylamine was purchased from Spectrum Chemicals
(New Jersey, USA). Organic solvents were of analytical
grade and purchased from Gadot Biochemical Industries
LTD. (Haifa, Israel). All other buffers and chemicals
were of analytical grade. SPI was kindly provided by
CHS (Minnesota, USA).
Design and production of plasmid vectors
The engineered plasmid was based on the S2P transgluta-
minase produced by random mutagenesis by Pietzsch et al.
[29], using the construct of the pro-domain and mature
transglutaminase expressed one following the other [18].
The construct consisted of a NdeI restriction enzyme site
followed by a pelB sequence before the pro-domain se-
quence with a stop codon, a spacer of 54 bps containing
another RBS (5’GGATAACAATTCCCCTCTAGAAATAATTTTGTTTAACTTTAAGAAGGAGATATA3’) and then
another pelB sequence followed by the mature transgluta-
minase sequence with a hexa histidine-tag for purification
and finally a BamHI restriction enzyme site (Fig. 1). The
construct was optimized and synthesized by GenScript
(NJ, USA), and amplified using a PCR reaction with for-
ward primer 5’CCCAAACATATGAAATACCTGCTG
CCG3’ and reverse primer 5’GTGTGTGGATCCTCA
GTGGTGGTGGTG3’ synthesized by HyLabs (Rehovot,
Israel) with a Phusion DNA polymerase (Thermo Fisher;
Massachusetts, USA) in a 50 μl reaction using a thermocy-
cler (Tpersonal; Biometra, Göttingen, Germany). The PCR
program had an initial denaturation step for 30 s at 98 °C,
followed by 30 cycles of 30 s at 98 °C, 30 s at 73 °C and
1 min at 72 °C followed by a final elongation step of
10 min at 72 °C. The PCR product was purified using a
QIAquick PCR Purification Kit (Qiagen; Hilden, Germany).
The PCR product and the vector pET9a (Novagen;
Darmstadt, Germany) were both digested with NdeI and
BamHI, and were then ligated with T4 DNA ligase (Pro-
mega; Madison, Wisc., USA). The ligated plasmid was
transformed into competent E. coli BL21 (DE3) using a
GeneZapper (Bio-Rad; Hercules, Calif., USA), and grown
on LB agar plates containing kanamycin (25 μg/ml).
Plasmids from colonies signifying successful transform-
ation, were extracted using a plasmid miniprep kit (Qiagen;
Hilden, Germany), and sequenced for verification.
The WT plasmid was produced by reverse mutation of
the synthesized S2P variant using a primer containing
the WT serine in position 2. The forward primer used
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CGC GTG ACC 3’, and reverse primer used was 5’ GGT
CAC GCG ATC ATC CGA GTC CAT CGC CAT CGC
3’. Taq polymerase (EurX; Gdańsk, Poland) was incu-
bated in a thermocycler (Tpersonal; Biometra, Göttin-
gen, Germany) with the purified pET9a plasmid
containing the synthesized gene. The PCR program had
an initial denaturation step for 30 s at 94 °C, then 30 cy-
cles of 10 s at 94 °C 30 s at 75 °C and 6 min at 74 °C,
followed by a final elongation step for 10 min at 74 °C.
The template plasmid was digested for 18 h at 37 °C
with a Dpn1 enzyme (NEB; Massachusetts, USA). The
resulting plasmid was prepped, used for transformation,
and verified by sequencing in the same manner as the
S2P mutant plasmid. To evaluate the benefit of using
pET9a instead of pET22b originally used, the TG gene
was transferred from the pET9a to the pET22b using
standard methods.Expression and purification of mTG
Transformed E. coli were grown on LB plates containing
kanamycin overnight at 37 °C and seeded into 500 ml
Terrific Broth containing 25 μg/mL kanamycin. After in-
cubation for 60 h at 25 °C, the samples were centrifuged
at 4,000 rpm for 15 min and 4 °C. The resulting pellet was
resuspended in binding buffer (500 mM NaCl, 30 mM
imidazole) and thrice passed through a homogenizer
(EmulsiFlex-C3, AVESTIN Inc.; Ottawa, Canada) at
1,500 bar. The cell debris was removed from the super-
natant by centrifuging twice at 16,000 g for 20 min at 15 °
C, whereas the supernatant was applied to a nickel affinity
column (HisTrap 5 ml; GE Healthcare; Buckinghamshire,
United Kingdom) primed with the binding buffer.
Elution was performed using a linear gradient with an
appropriate buffer (500 mM NaCl, 500 mM imidazole).
The fractions containing TG were collected and dialyzed
against a phosphate buffer at 4 °C (50 mM sodium phos-
phate buffer pH 8). Protein concentration was calculated
with a NanoDrop 2000 (Thermo Fisher Scientific Inc.
Massachusetts, USA) using a molar extinction coeffi-
cient of 71,850 1/M⋅cm and molecular weight of
39.07 kDa, calculated using the ProtParam (Swiss Insti-
tute of Bioinformatics) online software.SDS-PAGE analysis
SDS-PAGE was performed according to the Laemmli
discontinuous buffer system [51] using a 4% stacking gel
and 12% separating gel. The samples mixed with sample
buffer were heated for 10 min at 95 °C. After running,
the gel was stained with 0.25% Coomassie brilliant blue
(R-250) solution (40% Coomassie, 50% ethanol, 10%
acetic acid), and destained in a destain solution (20%
methanol, 10% acetic acid, 60% dH2O (v/v/v)).Hydroxamate activity assay
mTG activity was determined using the hydroxamate
assay at pH 6.0 and 37 °C [30]. Briefly, 200 μL substrate
mixture comprising 66.5 mM Z-Gln-Gly, 440 mM hy-
droxylamine, 2.2 mM EDTA, in 445 mM Tris-acetate
pH 6.0 were incubated at 37 °C for 5 min. An mTG so-
lution (50 μL) in 50 mM sodium phosphate buffer pH 8
was added. After 10 min of reaction, 250 μL of assay re-
agent (2 M FeCl3, 0.3 M Trichloroacetate, 0.8 M HCl)
was added and centrifuged for 5 min at 13,300 rpm. The
supernatant was transferred to a microplate, and the
resulting color was measured at 525 nm. Activity was
calculated by comparing to a calibration curve using L-
glutamic acid γ-monohydroxamate from 0 to 5 mM.
One unit was defined as the formation of 1 μmol prod-
uct per minute.
For determination of thermostability, 0.5 mg/ml of
WT and S2P enzymes were loaded into the capillary
tubes of a Prometheus NT.48 nanoDSF (NanoTemper
Technologies GmbH; Germany), and heated at a rate of
2 °C/min. Melting temperatures (Tm) were calculated by
the NT Melting Control software. The Tm was deter-
mined by fitting the experimental data to a polynomial
function, in which the slope maxima are indicated by
the peak of its first derivative.
Kinetic constant analysis via a coupled enzyme assay
Kinetic constants were calculated using the coupled en-
zyme assay [30], in which the ammonia release from
mTG activity is coupled to the uptake by glutamate de-
hydrogenase (GDH). The ammonia, which is the bypro-
duct of mTG catalyzed transamidation reaction between
Z-Gln-Gly and hydroxylamine, was used as a substrate
for GDH.
The activity of GDH is dependent on NADH as a co-
factor, whose disappearance can be monitored at
340 nm. 180 μL reaction mixture per microplate well
contained 0.2 M MOPS pH 7.2, 1 mM EDTA, 10 mM
α-KG, 2U GDH, 10 mM hydroxylamine, 0.5 mM
NADH, and 0.25-50 mM Z-Gln-Gly final concentration.
The plate was equilibrated for 5 min at 37 °C prior to
addition of 20 μl mTG (1 U) or water instead of mTG as
a blank. The concentration of NADH was calculated
based on a calibration curve. Reactions were carried out
in a 96 multi-well plate, and the absorbance was re-
corded in a BioTek EON plate reader (Vermont, USA).
Kinetic constants were calculated using the Enzyme Kin-
etics toolbox in SigmaPlot 12 (Systat Software Inc.).
Stability in organic solvents
The enzymes were tested for stability in organic solvents
based on an activity assay in the presence of organic
solvents, and the activity after incubation in organic
solvents for 24 h at 4 °C. The relative activity in the
Javitt et al. BMC Biotechnology  (2017) 17:23 Page 9 of 10presence of organic solvents was based on the hydroxa-
mate activity assay [29]. The organic solvents were
added in addition to the substrate buffer before the
addition of the enzyme, to produce the desired final
concentration. Activity was corrected for the increased
volume due to the organic solvent, and compared to a
blank containing water instead of enzyme.
Residual activity after incubation in organic solvents
was also calculated based on the hydroxamate assay. 2.5
U/ml mTG was incubated in different concentrations of
organic solvents (10–80%) at 4 °C for 24 h. After incuba-
tion, 50 μl of mTG in organic solvents was used directly
in the standard hydroxamate assay. Activity was com-
pared to a blank of water instead of mTG. Activity of
mTG incubated in 50 mM sodium phosphate buffer
pH 8 at 4 °C for 24 h was set as 100%, and used as the
benchmark for the other activities.
Crosslinking of soy protein isolate (SPI)
1% SPI solution (w/v) was suspended in 50 mM SPB
pH 7.4 and stirred for 12 h at 4 °C. The solution was cen-
trifuged at 13,300 rpm for 5 min to remove non soluble
protein, and the supernatant was mixed with mTG to ob-
tain a 1:50 w/w solution. The solution was incubated at
37 °C in an orbital shaker (TU-400 MRC; Holon, Israel) at
200 rpm for 4 h. Two controls were incubated in the same
conditions consisting of either mTG in water or SPI in
water. Samples from the reactions were taken at 0, 15, 30,
45, 60, 120, and 240 min and mixed with SDS-PAGE sam-
ple buffer to stop the reaction and prepare the fractions for
SDS-PAGE gel visualization.
Statistical analysis
The significance of differences between means was de-
termined by paired sample Student’s t test. The level of
significance used was 95% or higher.
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